XNAS
ROIV
Market cap6.48bUSD
Apr 08, Last price
9.08USD
1D
-1.94%
1Q
-17.60%
IPO
-12.69%
Name
Roivant Sciences Ltd
Chart & Performance
Profile
Montes Archimedes Acquisition Corp. focuses to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was founded in 2020 and is based in Menlo Park, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | |
Income | ||||||
Revenues | 124,795 103.65% | 61,280 10.84% | ||||
Cost of revenue | 529,700 | 1,138,849 | ||||
Unusual Expense (Income) | ||||||
NOPBT | (404,905) | (1,077,569) | ||||
NOPBT Margin | ||||||
Operating Taxes | 22,224 | 5,190 | ||||
Tax Rate | ||||||
NOPAT | (427,129) | (1,082,759) | ||||
Net income | 4,348,926 -453.56% | (1,230,024) 33.10% | ||||
Dividends | (6,000) | |||||
Dividend yield | 0.07% | |||||
Proceeds from repurchase of equity | 438,555 | 371,957 | ||||
BB yield | -5.01% | -7.07% | ||||
Debt | ||||||
Debt current | 21,893 | 52,413 | ||||
Long-term debt | 535,014 | 494,160 | ||||
Deferred revenue | ||||||
Other long-term liabilities | 29,339 | 80,578 | ||||
Net debt | (6,231,919) | (1,449,859) | ||||
Cash flow | ||||||
Cash from operating activities | (765,268) | (843,393) | ||||
CAPEX | (1,382) | (12,690) | ||||
Cash from investing activities | 5,203,623 | (44,269) | ||||
Cash from financing activities | 419,364 | 499,462 | ||||
FCF | (400,742) | (1,088,147) | ||||
Balance | ||||||
Cash | 6,541,073 | 1,692,115 | ||||
Long term investments | 247,753 | 304,317 | ||||
Excess cash | 6,782,586 | 1,993,368 | ||||
Stockholders' equity | 1,052,037 | (3,325,550) | ||||
Invested Capital | 5,925,580 | 5,494,577 | ||||
ROIC | ||||||
ROCE | ||||||
EV | ||||||
Common stock shares outstanding | 831,049 | 712,791 | ||||
Price | 10.54 42.82% | 7.38 49.39% | ||||
Market cap | 8,759,261 66.51% | 5,260,398 58.99% | ||||
EV | 3,007,290 | 4,260,360 | ||||
EBITDA | (382,869) | (1,058,712) | ||||
EV/EBITDA | ||||||
Interest | 34,778 | 27,968 | ||||
Interest/NOPBT |